X4 Pharmaceuticals earnings were -$37.5M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest XFOR earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$39.8M, up 8.5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, XFOR reported annual earnings of -$37.5M, with -63% growth. The next XFOR earnings date is May 5, 2025.
What were X4 Pharmaceuticals's earnings last quarter?
On XFOR's earnings call on Invalid Date, X4 Pharmaceuticals (NASDAQ: XFOR) reported Q4 2024 earnings per share (EPS) of -$6.00, up 122.22% year over year. Total XFOR earnings for the quarter were -$39.82 million. In the same quarter last year, X4 Pharmaceuticals's earnings per share (EPS) was -$2.70.
The next XFOR earnings call is Invalid Date. Add XFOR to your watchlist to be reminded of X4 Pharmaceuticals's next earnings date.
What was XFOR's earnings growth in the past year?
As of X4 Pharmaceuticals's earnings date in Invalid Date, X4 Pharmaceuticals's earnings has grown year over year. XFOR earnings in the past year totalled -$37.45 million.
Is X4 Pharmaceuticals profitable or losing money?
As of the last X4 Pharmaceuticals earnings report, X4 Pharmaceuticals is currently losing money. X4 Pharmaceuticals's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$37.45 million, a 62.98% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.